Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex Vivo Expanded Megakaryocytes for Supportive Care of Breast Cancer Patients: A Phase I/II Study

NCT00006225 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00006225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex Vivo Expanded Megakaryocytes for Supportive Care of Breast Cancer Patients: A Phase I/II Study
Lead sponsor
Northwestern University
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 1999
Completion date
January 31, 2004
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, myelodysplastic/myeloproliferative diseases